IndiaInfoline » Markets » DIVISLAB

Divis Laboratories Ltd - Share Price

DIVISLAB

Open

3,230.00

Prev. Close

3,211.15

Turnover (lac.)

112,467

Day's High

3,389.00

Day's Low

3,228.00

52 Week's High

3,349.40

52 Week's Low

1,570.50

Book Value

294

Face Value

2

Mkt Cap (Cr.)

88,783

P/E

55.62

EPS

60.18

Divi. Yield

0.48

Divis Laboratories LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Divis Laboratories LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd523.3542.13125,545.20531.950.762,878.64101.68
Divis Laboratories Ltd3,344.4055.6288,857.64492.250.481,709.96275.61
Dr Reddys Laboratories Ltd5,333.3526.5288,559.05950.200.473,244.40919.82
Cipla Ltd806.2529.1265,059.01610.300.503,035.72215.83
Biocon Ltd454.00154.8854,456.0084.800.00520.7062.80

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Divis Laboratories LtdSummary & Reports

Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More

Registered Office

1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli,Hyderabad, Telangana,500032

Tell. : +91-40-23786300/23786352/400
Website : http://www.divislaboratories.com
Email : mail@divislabs.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by divis-laboratories-ltd

View

- <

Reco. Price

Sep 16,2020 04:35 PM

Target Price

Target Returns:

0.00%

Result Express

Divis Laboratories Ltd's Q3FY19 standalone net profit rises 68.92% yoy to Rs379.49cr : In-line with Estimates

Sep 18, 2020 08:12 PM

The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    AGM

    Exp. Date

    14 Sep 2020

    Annc. Date

    17 Aug 2020

    AGM 14/09/2020As already informed vide our letter dated 17 August, 2020, the 30th Annual General Mee... More

  • Purpose

    Board Meeting

    Exp. Date

    08 Aug 2020

    Annc. Date

    29 Jul 2020

    DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More

  • Purpose

    Board Meeting

    Exp. Date

    06 Jun 2020

    Annc. Date

    30 May 2020

    DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More